Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections

Abstract Biomedical device-associated infection is one of the most common and problematic complications faced by millions of patients worldwide. The current antibiotic therapy strategies face challenges, the most serious of which is antibiotic resistance. Studies have shown that the systemic level o...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials 2009-05, Vol.30 (13), p.2552-2558
Main Authors: Li, Bingyun, Jiang, Bingbing, Boyce, Brandon M, Lindsey, Brock A
Format: Article
Language:English
Subjects:
Advanced Basic Science
Animals
Antimicrobial
Biomedical Technology
Bone
Cytokine
Dentistry
Disease Models, Animal
Drug delivery
Fractures, Bone - pathology
Humans
Infection
Infection Control
Interleukin-12 - chemistry
Interleukin-12 - pharmacology
Microscopy, Electron, Scanning
Nanostructures - chemistry
Peptides - chemistry
Rats
Static Electricity
Surface modification
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Biomedical device-associated infection is one of the most common and problematic complications faced by millions of patients worldwide. The current antibiotic therapy strategies face challenges, the most serious of which is antibiotic resistance. Studies have shown that the systemic level of interleukin 12 (IL-12) decreases following major injuries resulting in decreased cell-mediated immune response. Here we report the development of IL-12 nanoscale coatings using electrostatic layer-by-layer self-assembly nanotechnology. We found that IL-12 nanoscale coatings at the implant/tissue interface substantially decrease infections in vivo , and IL-12 nanoscale coatings are advantageous over traditional treatments. This approach could be a revolutionary step toward preventing device-associated infections using a non-antibiotic approach.
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2009.01.042